Click here for the October edition of eNews.
The Biosphere, a specialist lab facility on Newcastle Helix, has welcomed yet another Newcastle University spin-out, who has developed and commercialised a prognostic test for early-stage skin cancer.
Formed in 2017, AMLo Biosciences’ first product (AMBLor) - a ground-breaking melanoma test will go to market in 2021. AMBLor will be launched in both the UK, USA and Australia and has the potential to save up to 2,000 lives every year as well as reassure thousands of others that their early stage skin cancer will not progress. This first-in class diagnostic identifies the metastatic…
Biohazards are understandably in the spotlight again, due to COVID-19. As a health and safety consultancy specialising in the scientific sector, Bishop Simon Ltd was asked by the Institution of Occupational Safety and Health Magazine to contribute to their article “ARE YOU PREPARED FOR THE NEXT BIOHAZARD” - https://www.ioshmagazine.com/2020/09/09/are-you-prepared-next-biohazard. The article focuses on health and safety practices that organisations are applying to meet the challenges of outbreaks. Our focus was on how organisations can positively influence the behaviour of their workforce in…
Below you'll find a list of events and conferences where One Nucleus will be in attendance. Feel free to reach out during these conferences to speak to our BD team.
We can offer a discount on registration, to our members, to many of the below. Get in touch here for discount codes.
8 October - Optimum Communications Annual Healthcare Investor Conference
14-15 October - UK Bioscience Forum
15 October - MedTech Integrates
26-27 October - SynbiTECH
27-30 October - MedTech Innovation Forum
26-29 October - BIO-Europe
09-12 November - …
Cambridge, UK, 05 October 2020: Chesterford Research Park is delighted to confirm that Oncologica has secured the last available suite within the newly re-configured Newnham building at the Park and will take up occupancy with immediate effect post partial practical completion, which is due within the next week.Ideal for occupiers looking for grow-on space, the existing Newnham Building has been significantly overhauled and re-configured to create an imposing, detached two storey fully fitted lab/R&D building. Situated in a prominent position on the Park, the re-configuration…
SOMERSET, N.J. – October 1, 2020 — Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the launch of its new OneXpress™ service for the integrated development, scale up and manufacturing of new oral solid dosage forms.
The OneXpress solution accelerates a program’s transition from early-phase development to commercial-ready manufacturing by leveraging Catalent’s phase-appropriate scale, technologies, extensive oral dose form network and…
SOMERSET, N.J. – October 1, 2020— Catalent, a global leader in clinical supply services, has announced that its clinical supply site in Bathgate, West Lothian has won Scottish Engineering’s ‘Vice President Award 2020,’ recognising its continuous improvement programme in core values including “patient first, customer dedication, people, innovation, integrity and excellence.”
The award was presented to Catalent’s General Manager of the Bathgate facility, Dianne Coughlan, at an official ceremony at Scottish Engineering’s Glasgow headquarters on Sept. 18.
Speaking at the ceremony, Ms. Coughlan…
AMSBIO is launching a new range of human iPSC-derived cells and human iPSC differentiation reagent kits optimized for high-throughput experiments in areas including drug discovery and toxicity screening.These new products are based upon a novel technology platform that relies on key transcription factor (TF) genes, a combination of which determines the identity of cells. These TFs are so powerful that they can rapidly and efficiently differentiate human iPS cells into specific cell types, such as neurons and skeletal muscle cells. These transcription factors are…
BERLIN, GERMANY and SOMERSET, N.J. – September 21, 2020 — T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor (TCR) program.
T1367 is an autologous T-cell…
Reading Scientific Services Ltd (RSSL) has expanded its pharmaceutical assessment capabilities with the introduction of a robust analytical method designed to determine the presence of nitrosamines. Using highly-sensitive mass spectrometers in conjunction with a range of separation techniques, the new service can not only reach exceptionally low regulatory thresholds, but also accommodate a wide variety of pharmaceutical products and active species.
The move enables the scientific consultancy to respond to urgent market demand for greater nitrosamine testing capacity, as Dr Daniel Nicolau,…